By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genia, a Mountain View, Calif.-based startup, is developing a semiconductor-based nanopore sequencing platform that it believes will show promise for molecular diagnostic applications.

Stefan Roever, CEO and founder of the company, told GenomeWeb Daily News this week that the company has an alpha version of its single-molecule platform in hand and is currently optimizing the biochemistry for a beta system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.